The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission.
D000731:Androstanes; D000736:Androstenes / Q000494:pharmacology*; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects*; D001378:Azasteroids / Q000494:pharmacology*; D002415:Cats; D002800:Cholinesterase Inhibitors; D005260:Female; D005730:Ganglionic Blockers; D006168:Guinea Pigs; D006718:Homosteroids / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010791:Phrenic Nerve / Q000187:drug effects; D051381:Rats; D013260:Steroids, Heterocyclic / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects*; D014630:Vagus Nerve / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000731:Androstanes; D000736:Androstenes; D001378:Azasteroids; D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D006718:Homosteroids; D009466:Neuromuscular Blocking Agents; D013260:Steroids, Heterocyclic; C021177:dihydrochandonium